Anti-corruption: All roads lead to enforcement

When it comes to corruption, Life Sciences companies are a frequent target of investigation and enforcement. The French enactment of Sapin II is the latest in a long line of laws to combat corruption. This article explores Sapin II and why the authors feel that Life Sciences companies are among the best positioned to comply with Sapin II’s requirements.

To read the article by Amy Greenstein, Caroline Franco, Darren Jones and Veronique Monjardet

Check Also

Australia | Pharma reporting still leaves gaps in money trail

The latest figures on drug company spending on healthcare professionals have been released, with six …